Month: May 2023

Oral GLP-1 agonist GSBR-1290 advancing into Phase 2a study in type 2 diabetes and obesity Topline data from Phase 1b multiple ascending dose and Phase 2a studies of GSBR-1290 expected in second half 2023 SAN FRANCISCO and SHANGHAI, May 11, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today reported financial results for the first quarter ended March 31, 2023, and highlighted recent corporate achievements. “We are rapidly advancing GSBR-1290, our lead program in our oral GLP-1 franchise,” said Raymond Stevens, Ph.D., Founder and CEO of Structure Therapeutics. “Type 2 diabetes and obesity are increasing in prevalence worldwide and it is important to provide patients with...

MARKHAM, Ontario, May 11, 2023 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three months ended March 31, 2023. The Consolidated Financial Statements and accompanying Management’s Discussion and Analysis (“MD&A”) are available on the Company’s website at www.siennaliving.ca and on SEDAR at www.sedar.com. Sienna’s significant progress with respect to a number of strategic initiatives and its effective cost management resulted in strong year-over-year financial results in Q1 2023. “As we move further into 2023, we have many reasons to be encouraged,” said Nitin Jain, President and Chief Executive Officer. “Strong demand for our retirement residences supported significant year-over-year growth in our same-property NOI, our long-term care communities...

HOUSTON, May 11, 2023 (GLOBE NEWSWIRE) — Koil Energy Solutions, Inc. (OTCQB: KLNG) (“Koil Energy” or the “Company”), a specialist in deepwater production and distribution equipment and services, today reported results for the quarter ended March 31, 2023. Koil Energy at a Glance:Share Price†: $0.65 Cash*: $1.5M52-Week Range†: $0.42 – $0.80 Book Value*: $7.0MShares Out.†: 11.9M Price / Book Value: 1.1xMarket Cap†: $7.7M TTM Revenue: $13.1M*As of 03/31/23; †As of 05/10/23      Charles Njuguna, Koil Energy’s CEO, commented, “Our top-line results for the first quarter of 2023 are reflective of the positive trends in offshore activity that we are currently experiencing. We remain constructive on our outlook on the energy markets for 2023 and beyond and believe that we are currently in the midst of a ramp up in...

BOCA RATON, Fla., May 11, 2023 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer and payment solution provider for underserved consumers, today announced its financial results for the quarter ended March 31, 2023. Results for Quarter Ended March 31, 2023 vs. Quarter Ended March 31, 2022:  ● Total fundings increased 29.2% to $27.4 million from $21.2 million consisting of gross lease originations decreasing from $16.3 to $13.2 million, loan participations decreased ~96.2% from $4.9 million to $0.2 million, and loan originations increasing from $0 to $14.0 million       ● Total net lease and loan revenues and fees increased 6.3% to $30.8 million from $28.9 million       ● Gross profit increased 45.2% to $13.6 million from $9.4 million       ● Adjusted...

SALINAS, Calif., May 11, 2023 (GLOBE NEWSWIRE) — Lowell Farms Inc. (“Lowell Farms” or the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born vertically integrated cannabis company with advanced production capabilities including cultivation, extraction, manufacturing, and distribution, announces unaudited revenue and operating results for the first quarter of 2023 (ended March 31, 2023). All figures stated are in US Dollars. First Quarter Financial Highlights Revenues:       Net revenue generated for Q1 2023 decreased 39% to $7.5 million, as compared to $12.4 million for Q1 2022. Net revenue was $9.3 million for Q4 2022, a decrease of 19%.CPG revenue decreased 49% compared to Q1 2022, and decreased 18% compared to Q4 2022. Bulk revenue from self-grown wholesale products increased 44% compared to Q1 2022 and decreased 9%...

CALGARY, Alberta, May 11, 2023 (GLOBE NEWSWIRE) — Cardinal Energy Ltd. (“Cardinal” or the “Company”) (TSX: CJ) is pleased to announce its operating and financial results for the first quarter ended March 31, 2023. FINANCIAL AND OPERATING HIGHLIGHTS FROM THE FIRST QUARTER OF 2023Production increased 5% over the same period in 2022 due to ongoing strong base performance and excellent 2022 drilling results across our asset base;Adjusted funds flow(1) was $52.3 million which was allocated to capital expenditures(1) of $25.3 million and dividends of $28.7 million;Cardinal’s net debt(1) has decreased by 47% in the last 12 months closing at $78 million at March 31, 2023;Achieved a net debt to adjusted funds flow ratio(1) of 0.2x for the first quarter of 2023;In the last 12 months, Cardinal has...

CALGARY, Alberta, May 11, 2023 (GLOBE NEWSWIRE) — TSX-V: CWV: Crown Point Energy Inc. (“Crown Point”, the “Company” or “we“) today announced its operating and financial results for the three months ended March 31, 2023. Copies of the Company’s March 31, 2023 unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) filings are being filed with Canadian securities regulatory authorities and will be made available under the Company’s profile at www.sedar.com and on the Company’s website at www.crownpointenergy.com. All dollar figures are expressed in United States dollars (“USD”) unless otherwise stated. References to “ARS” are to Argentina Pesos. In the following discussion, the three months ended March 31, 2023 may be referred to as “Q1...

SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2023 and provided an update on its corporate activities and product pipeline. “The recently received $20.0 million milestone payment from Melinta Therapeutics following the U.S. Food and Drug Administration (FDA) approval of REZZAYOTM (rezafungin for injection) further strengthened our balance sheet,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. “Importantly, we remain eligible to receive additional non-dilutive capital of up to approximately $47.1 million in development and regulatory milestones...

TORONTO, May 11, 2023 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the first quarter of 2023. David Clare, President and CEO of Trisura, stated, “Trisura reported strong performance in the quarter with operating net income of $28.6 million, or $0.61 per share. Quarterly net income of $14.0 million, or $0.30 per share, was impacted both by the implementation of new IFRS standards and the run-off of a US program. Expansion of distribution relationships and maturation of our platform drove increased market share and resulted in insurance revenue growth of 58.3%. In Canada, disciplined underwriting yielded a combined ratio of 80.7%. Our US fronting business produced $459.3 million of insurance revenue and reported deferred...